Neurocrine Biosciences In...

NASDAQ: NBIX · Real-Time Price · USD
132.85
1.54 (1.17%)
At close: Aug 15, 2025, 3:59 PM
132.90
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT

Neurocrine Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
348.3M 305.8M 341.3M 385.9M 339.2M 369.7M 249.7M 191M 176.4M 64M 154.5M 58.2M 12.2M 71.4M 89.6M 444.8M 364.7M 402M
Depreciation & Amortization
28.5M 28.5M 27.1M 25.7M 24.7M 22.5M 21.3M 20M 18.5M 17.3M 15.6M 14.2M 13M 11.7M 10.9M 10.1M 9.5M 9M
Stock-Based Compensation
213.5M 203.8M 195.5M 167.2M 173.5M 198.9M 194.3M 199.7M 195M 176M 173.1M 165.2M 159.2M 138.3M 134.2M 119.6M 109.2M 110.1M
Other Working Capital
85.1M 81.2M 78.4M 26.1M -6M 69.3M 47.8M -77.3M -44.9M -107.8M -94.2M -16M -24.7M -29.4M -17M -43.7M -44.8M -34.8M
Other Non-Cash Items
-4.4M 240.7M 399.6M 361.8M 384.9M 126.6M -46.9M -17.9M -61.9M -18.6M -32.9M -54.3M -29.4M -24M 800K 59.2M 51M 49.4M
Deferred Income Tax
-117.3M -121.2M -123.1M -71.2M -40.5M -40.7M -56.7M -63.8M -50.6M -12.2M 19.1M 900K -2.4M 10.2M 4.3M -301.7M -300.4M -321.2M
Change in Working Capital
98.7M 12.4M -19.2M -167.2M -125.6M 54.1M 28.2M 80.4M 18.8M -49.2M -67.4M -61M -66.4M -78.9M 16.7M 9.2M 27.9M 28.3M
Operating Cash Flow
567.3M 529.9M 595.4M 476.4M 530.4M 645.4M 389.9M 409.4M 296.2M 254.7M 339.4M 200.6M 163.6M 128.7M 256.5M 341.2M 261.9M 277.6M
Capital Expenditures
-38.6M -37.7M -38.2M -36.3M -35.8M -31M -28.3M -24.7M -15.4M -17.4M -16.5M -23.6M -31M -26.5M -23.4M -19M -13.7M -14.1M
Cash Acquisitions
n/a n/a n/a 5.4M 95.1M 101.9M 99.7M 51.6M -39.8M -46.6M -56.6M -13.9M -12.2M -12.2M -700K -700K -700K -700K
Purchase of Investments
-1.13B -1.01B -1.06B -1.23B -1.36B -1.49B -1.41B -1.16B -928.8M -665.9M -628.9M -537M -683M -911.5M -804.7M -999.6M -830M -657.2M
Sales Maturities Of Investments
1.11B 989.3M 967.5M 1.01B 1.02B 1.04B 972.4M 843.8M 642M 538.4M 511M 522.8M 611.3M 713.1M 697.9M 717M 693.5M 705.3M
Other Investing Acitivies
n/a -16.6M -60.4M -65.8M -155.5M -145.7M -99.7M -165.4M -74M -27M -17M 54.1M 52.4M 12.2M 700K 700K 700K 700K
Investing Cash Flow
-58.4M -57.6M -126.8M -260.3M -382.3M -480M -467.1M -380.9M -344.9M -187.6M -177.1M -37.8M -102.7M -224.9M -130.2M -301.6M -150.2M 34M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a -279M -279M -279M -279M n/a -100K -100K -100K -100K
Common Stock Repurchased
-167.7M -150M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-381.5M -690.3M -502.5M -177.1M -184.7M 127M 65.3M 54.5M 47.1M 46.8M 38.6M 15.8M 11.9M 12.3M 27.5M -161.2M -168.7M -171.7M
Financial Cash Flow
-384.8M -674.5M -486.7M -161.3M -168.9M 127M 65.3M 54.5M 47.1M -232.2M -234.3M -257.1M -261M 18.4M 27.4M -153.8M -158.8M -146M
Net Cash Flow
124.3M -202.2M -18.1M 55.4M -20.5M 292.7M -11.6M 81.7M -2.9M -166.4M -73.3M -94.3M -200.1M -77.8M 153.7M -114.2M -47.1M 165.6M
Free Cash Flow
528.7M 492.2M 557.2M 440.1M 494.6M 614.4M 361.6M 384.7M 280.8M 237.3M 322.9M 177M 132.6M 102.2M 233.1M 322.2M 248.2M 263.5M